Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation

BACKGROUND: Although trastuzumab provides significant clinical benefit for HER2-positive breast cancers, responses are limited by the emergence of resistance. Recent evidence suggests that long noncoding RNAs (lncRNAs) play important roles in tumorigenesis and chemoresistance. However, the regulator...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cancer
Main Authors: Han, Mingli, Gu, Yuanting, Lu, Pengwei, Li, Jingyi, Cao, Hui, Li, Xiangke, Qian, Xueke, Yu, Chao, Yang, Yunqing, Yang, Xue, Han, Na, Dou, Dongwei, Hu, Jianguo, Dong, Huaying
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7001272/
https://ncbi.nlm.nih.gov/pubmed/32020881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-020-1145-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados